CIS Pharma presenting ADC drug carrier technology at Swiss Biotech Day 2017

Basel, Switzerland, May 4th 2017 -- CIS Pharma presents its ADC drug carrier technology at Swiss Biotech Day 2017, scheduled for 14:10 during the Emerging Companies Streams. CIS Pharma ADC [...]

By | Mai 1st, 2017|ADC, Cellophil, Corporate|0 Comments

CIS Pharma appoints Dr. Christophe Thommen as new head of research and laboratory operations

Bubendorf, Switzerland, December 2016 -- CIS Pharma welcomes Dr. Christophe Thommen, who will lead the research team as the new head of research and laboratory operations. Christophe is an expert [...]

By | Dezember 1st, 2016|ADC, Cellophil, Corporate|0 Comments

CIS Pharma announces the first milestones in its ADC research program are achieved

Bubendorf, Switzerland, January 2016 -- Proof of concept studies at NBE Therapeutics demonstrated conjugation of CIS Pharma’s Cellophil® Smart Polymer drug carrier to antibodies. Consequently, different linkers were evaluated for [...]

By | Januar 1st, 2016|ADC, Cellophil|0 Comments

CIS Pharma appoints Davide Panighetti to its cancer research team

Bubendorf, Switzerland, April 2015 -- CIS Pharma welcomes Davide Panighetti, who reinforces the research team as the new synthesis chemist. Davide’s skills will boost the team working on proprietary drug [...]

By | April 1st, 2015|ADC, Cellophil, Corporate|0 Comments

CIS Pharma to develop drug carriers for ADCs

Bubendorf, Switzerland, January 2015 -- CIS Pharma has taken a strategic decision to extend its activity into the field of cancer treatments. The defined objective is to improve the potency [...]

By | Januar 1st, 2015|ADC, Cellophil|0 Comments